<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02046057</url>
  </required_header>
  <id_info>
    <org_study_id>5140020</org_study_id>
    <nct_id>NCT02046057</nct_id>
  </id_info>
  <brief_title>Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer</brief_title>
  <acronym>ENCASe</acronym>
  <official_title>Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine if it is possible to identify and perform a needle&#xD;
      biopsy of the sentinel lymph node. The investigators hope to identify breast cancer cells in&#xD;
      the lymph nodes under the arm without making an operation necessary.&#xD;
&#xD;
      The rationale for this study is that for patients without enlarged lymph nodes under the arm,&#xD;
      sentinel lymph node biopsy is the standard way of determining if breast cancer has spread to&#xD;
      the lymph nodes under the arm. While the complications from a sentinel lymph node dissection&#xD;
      are less than that of a complete axillary lymph node dissection, sentinel lymph node&#xD;
      dissection still carries small risks of arm swelling, decreased movement, fluid collections,&#xD;
      nerve injury, and pain. Furthermore, the majority of sentinel lymph nodes do not contain&#xD;
      cancer. The investigators hope to develop a method to find cancer in the axillary lymph nodes&#xD;
      and avoid the complications of an operation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients already scheduled to undergo sentinel lymph node dissection in the operating&#xD;
      room, the investigators will first perform an axillary ultrasound guided core needle biopsy&#xD;
      percutaneously. Patients will have already undergone prior injection of radioisotope and blue&#xD;
      dye and as a standard procedure or the sentinel lymph node dissection. After induction of&#xD;
      anesthesia, the investigators will identify the location of the sentinel node with a gamma&#xD;
      probe to identify the &quot;pre-incision hot spot.&quot; Axillary ultrasound will then be used to&#xD;
      identify the location of the lymph node and a percutaneous core needle biopsy of the targeted&#xD;
      lymph node will be performed. The core biopsy specimen will be evaluated for the presence of&#xD;
      blue staining and radioisotope uptake intraoperatively. The core biopsy specimen will then&#xD;
      will be sent for pathologic analysis. The percutaneous biopsy should take about 10 minutes of&#xD;
      additional operating room time. The operation will then proceed as planned with dissection&#xD;
      and removal of the remaining sentinel node(s). Core samples and sentinel lymph nodes will be&#xD;
      evaluated in a similar fashion per existing sentinel node protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Awaiting additional funding&#xD;
  </why_stopped>
  <start_date type="Actual">February 12, 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of axillary ultrasound guided percutaneous needle biopsy of sentinel node</measure>
    <time_frame>2 years</time_frame>
    <description>False positive and false negative rates of ultrasound guided needle biopsy of sentinel node will be determined by comparison of results with gold standard of open surgical sentinel node dissection.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>PNB of SLN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous core biopsy of sentinel node prior to standard sentinel node dissection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PNB of SLN</intervention_name>
    <description>Percutaneous biopsy of sentinel node</description>
    <arm_group_label>PNB of SLN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Breast cancer patients eligible for sentinel node dissection&#xD;
&#xD;
          -  Invasive ductal or invasive lobular carcinoma&#xD;
&#xD;
          -  Ductal carcinoma in situ undergoing total mastectomy&#xD;
&#xD;
          -  Clinically node-negative&#xD;
&#xD;
          -  18-100 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inflammatory breast cancer&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Preoperative chemotherapy&#xD;
&#xD;
          -  Prior axillary ultrasound guided core needle biopsy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon S Lum, MD,FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>January 22, 2014</study_first_submitted>
  <study_first_submitted_qc>January 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2014</study_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Sharon Lum, MD</investigator_full_name>
    <investigator_title>Associate Professor, Department of Surgery, Division of Surgical Oncology, MD , FACS</investigator_title>
  </responsible_party>
  <keyword>Sentinel Lymph Node</keyword>
  <keyword>Ultrasound Guided Needle Core Biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

